Memorial Sloan Kettering Cancer Center 3rd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy 2023
Format: 28 videos + 36 pdfs, size: 16.2 GB
Course Audience: hematologist, immunologist, internist, oncologist, critical care physician
Overview:
Date & Location
Friday, April 28, 2023, 9:00 AM – Saturday, April 29, 2023, 1:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Specialties
Specialties – Bone Marrow Transplant, Cellular Therapeutics, Critical Care, Hematology, Immunotherapy, Infectious Diseases, Internal Medicine, Medical Oncology, Pulmonary Medicine, Solid Tumor Oncology
Overview
This 3rd international Symposium will bring together a diverse group of experts and thought leaders in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss current advances in the field, mechanisms of toxicities, symptom burden, and late effects after HCT and cellular therapies along with best practices to prevent and treat these complications.
This unique 2-day program will be comprised of sessions dedicated to a wide range of pre-clinical, translational, and clinical topics, including cellular therapies as a model of accelerated aging, CAR T cell-related toxicities, infectious complications, decision science, the role of the gut microbiome in toxicities, debates on how to diagnose and treat difficult complications such as transplant-associated thrombotic microangiopathy, and several keynote lectures from world experts.
>> Who Should Attend
The target audience for this Symposium includes physicians, advanced practice providers (physician assistants and nurse practitioners), and nurses who treat or refer patients for hematopoietic cell transplantation or immune effector cell therapies (i.e., CAR T cells; tumor infiltrating lymphocytes, or T cell receptor therapy).
Available to in-person attendees only, the focus of this optional luncheon session is on Improving Outcomes with Active Acute Leukemia Undergoing Transplant — Do We Need to Reinduce Patients With Active AML?
Due to space, the luncheon is only available to 50 attendees and selection must be made during course registration. We do recommend early registration in order to secure your spot. Luncheon confirmation will be sent prior to the start of the Symposium.
We are pleased to invite the submission of abstracts for this Symposium. Abstracts will be selected on the basis of their scientific merit and content quality. Abstract submission is open to all, and we also highly encourage fellows, residents, pharmacists, and advanced practice providers to submit relevant abstracts in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted.
Objectives
- Identify the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
- Discuss the best practices in the prevention and treatment of toxicities and symptom burden after HCT and cellular therapy.
- Collaborate with a multidisciplinary group of colleagues to discuss, brainstorm, and plan future quality improvement and research efforts to reduce toxicities, improve the patient experience, and decrease non-relapse mortality.
A New, but Familiar Foe- IEC-HS (HLH) (Video MP4 Format)
A New, but Familiar Foe- IEC-HS (HLH) (PDF Format)
Abstracts Biopsy proven kidney specific-thrombotic microangiopathy without systemic markers of hemolysis in patients with chronic kidney disease (PDF Format)
Abstracts CAR T-Associated Infection- A Single-Center, Five-Year Retrospective (PDF Format)
Abstracts Connected Care Remote Monitoring after Discharge from Inpatient Autologous or Allogeneic Stem Cell Transplant (PDF Format)
Abstracts Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD (PDF Format)
Abstracts Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy- a pharmacovigilance analysis of the FDA reporting system (PDF Format)
Abstracts Encouraging Outcomes after Second Hematopoietic Cell Transplants with Unrelated Cord Blood Grafts for Post-Transplant Relapse in Pediatric Patients (PDF Format)
Abstracts Free interleukin-18 is elevated in CD22 CAR T-cell associated hemophagocytic lymphohistiocytosis-like toxicities (PDF Format)
Abstracts Intrathecal Hydrocortisone for Treatment of Children and Young Adults with CAR T-cell Immune-Effector Cell Associated Neurotoxicity Syndrome (PDF Format)
Abstracts Successful incorporation of electronic patient reported outcomes using PROMIS-29 into standard of care after hematopoietic stem cell transplant (PDF Format)
Adoption or De-adoption of Evidence Into Practice in Transplantation and Cellular Therapy (Video MP4 Format)
Adoption or De-adoption of Evidence Into Practice in Transplantation and Cellular Therapy (PDF Format)
Biomarkers of Aging in BMT and Next Steps in Our Field (Video MP4 Format)
Biomarkers of Aging in BMT and Next Steps in Our Field (PDF Format)
Blocking IFN- Enhancement of CAR T cell Proliferation Without Increasing CRS (PDF Format)
CAR T Toxicities Panel Discussion Q&A (Video MP4 Format)
CAR-HEMATOTOX- Prolonged Cytopenias After CAR T cell Therapy (Video MP4 Format)
CAR-HEMATOTOX- Prolonged Cytopenias After CAR T cell Therapy (PDF Format)
Cellular Therapies as a Model of Accelerated Aging Panel Discussion Q&A (Video MP4 Format)
CMV in the Lung- Pathogen, Paradigm, Puzzle (Video MP4 Format)
CMV in the Lung- Pathogen, Paradigm, Puzzle (PDF Format)
Cognitive Impacts of Accelerated Aging in BMT (Video MP4 Format)
Cognitive Impacts of Accelerated Aging in BMT (PDF Format)
Decision Science and Toxicities Panel Discussion Q&A (Video MP4 Format)
FMT as Prophylactic Supportive Care (Video MP4 Format)
FMT as Prophylactic Supportive Care (PDF Format)
FMT for Treatment of Acute GVHD (Video MP4 Format)
FMT for Treatment of Acute GVHD (PDF Format)
Harmonization of Toxicity Definitions – Challenges – Process and Example (Video MP4 Format)
Harmonization of Toxicity Definitions – Challenges – Process and Example (PDF Format)
HHV-6 Reactivation and Related Complications After HCT and CAR-T cell Therapies (PDF Format)
Immune Aging and Senolytics (Video MP4 Format)
Immune Aging and Senolytics (PDF Format)
Incorporating Patient Reported Outcomes Into Standard of Care Practice (Video MP4 Format)
Incorporating Patient Reported Outcomes Into Standard of Care Practice (PDF Format)
Infections as Toxicities Panel Discussions Q&A (Video MP4 Format)
Integrating Patient Values and Preferences Into Treatment Decision Making (Video MP4 Format)
Integrating Patient Values and Preferences Into Treatment Decision Making (PDF Format)
MSKTox2023_Brochure (PDF Format)
Nutrition and Microbiota in Allo-HCT (Video MP4 Format)
Nutrition and Microbiota in Allo-HCT (PDF Format)
Nutrition – Microbiome and Toxicities Panel Discussion Q&A (Video MP4 Format)
Nutritional Interventional Trial to Improve the Mircrobiome and Prevent Acute GVHD (Video MP4 Format)
Nutritional Interventional Trial to Improve the Mircrobiome and Prevent Acute GVHD (PDF Format)
Parkinsonian Neurotoxicity After BCMA CAR T cells (Video MP4 Format)
Parkinsonian Neurotoxicity After BCMA CAR T cells (PDF Format)
Plant Sequencing and Gut Microbiome in Allo-HCT (PDF Format)
Post CAR T Cell Infections (Video MP4 Format)
Post CAR T Cell Infections (PDF Format)
Pulmonary Toxicities of Cellular Therapies (Video MP4 Format)
Pulmonary Toxicities of Cellular Therapies (PDF Format)
Remote Performance Status Monitoring Using Wearables and PROs (Video MP4 Format)
Remote Performance Status Monitoring Using Wearables and PROs (PDF Format)
Respiratory Viral Infections- Acute and Persistent Lung Effects (Video MP4 Format)
Respiratory Viral Infections- Acute and Persistent Lung Effects (PDF Format)
Special Luncheon Debate (Video MP4 Format)
Special Luncheon Debate (PDF Format)
Transplant as a Model of Accelerated Aging (Video MP4 Format)
Transplant as a Model of Accelerated Aging (PDF Format)
Updates on the Diagnosis and Treatment of TA-TMA- Discussion with Experts (Video MP4 Format)
Updates on the Diagnosis and Treatment of TA-TMA- Discussion with Experts (PDF Format)
Viral Specific T Cell Therapy for Polyomavirus- Overcoming BK and JC Virus After Cell Therapy (Video MP4 Format)
Viral Specific T Cell Therapy for Polyomavirus- Overcoming BK and JC Virus After Cell Therapy (PDF Format)